Site search

Clear filter
2991 results for '' found
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (NCT07202546)
/
Concussion Incidence with Gamegear Nodal Impact Attenuation Headgear: A Multistate Randomised Crossover Clinical Trial in Australian Collision Sports (Trial Not Registered)
/
Fatigue In Relapsing Multiple Sclerosis Epstein-Barr Virus Treatment Trial (ACTRN12624000423516)
/
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Parallel Study to Evaluate the Efficacy and Safety of Enpatoran in Participants with Active Cutaneous Manifestations of Lupus Erythematosus With
/
A Phase III Open-label, Randomised, Multicentre Study Comparing AZD0120, a Dual-Targeting Autologous Chimeric Antigen Receptor T-cell [CAR-T] Therapy Directed Against BCMA and CD19, versus Standard Re
/
A Phase 2, randomized, open-label, controlled study to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe refractory idiopathic inflammatory
/
A multicenter, randomized, double-blind, placebo-controlled, dose-range Phase II study to assess the efficacy and safety of GIA632 in patients with non-segmental vitiligo not adequately controlle
/
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess Efficacy, Safety and Tolerability of BMB-101 Oral Solution for the Treatment of Patients with Prader-Willi Syndrome [PWS] (NCT072
/
A Phase III, randomised, double-blind, placebo-controlled study to assess the efficacy, safety, and tolerability of BI 1291583 2.5 mg administered once daily for up to 76 weeks in patients with bronch
/
Sleep Clinic Patient Initiated Review Information Sheet pdf
Sleep_Clinic_Patient_Initiated_Review_Information_Sheet.pdf
11 12 13 14 15